Overview

Minocycline in Patients With Huntington's Disease

Status:
Completed

Trial end date:
2003-08-01

Target enrollment:

Participant gender:

Summary

This is a study to determine whether treatment with minocycline is safe and tolerable in patients with Huntington's disease (HD) and whether minocycline reduces symptoms of HD in these patients.

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

FDA Office of Orphan Products Development

Treatments:

Minocycline